Interests: PCOS; Menopause; Infertility; Herbal Medicine
Special Issue Information
Due to social and economic changes, including population aging, birthrate declines, and increases in economic activity, the factors and countermeasures related to women’s health are changing rapidly.
Women’s health is related to the health of future generations, not on the individual level, but on the social and economic levels, and realization of this has contributed to the concept of comprehensive women’s health management, which includes the social and environmental factors that affect females’ health.
Approaching women’s health issues efficiently necessitates changes in awareness, social culture, and medical information and systems as well as the professional approach to delivering health care throughout women’s lives.
One needed change is to treat not only pregnancy and childbirth, but also diseases specific to women and serious health problems that occur more frequently in women using an approach that considers the life cycle. Countermeasures should also integrate various medical technologies.
Endocrinologic diseases, including infertility, miscarriage, premenopausal syndrome, and polycystic ovary syndrome, are complicated processes controlled by endocrine regulation. Complementary and integrative therapies (CIT) has been used widely to treat women’s reproductive endocrinologic diseases, but CIT’s safety and effectiveness have not been fully evaluated. To close these gaps, the use of CIT to treat women’s reproductive endocrinologic diseases must be evaluated using scientific research methods.
In this special issue, we provide scientific evidence regarding the use of CIT to manage women’s health.
The potential topics include but are not limited to the following:
• The clinical efficacy of CIT for treating dysmenorrhea, women’s infertility, perimenopausal syndrome, polycystic ovary syndrome, etc.
• The mechanisms of CIT, including acupuncture, aromatherapy, herbal medicine, hypnosis, massage, meditation, and tai chi.
• The adverse effects and risks of using CIT to treat women’s reproductive endocrine disorders.
Prof. Myeong Soo Lee, Associate Prof. Fan Qu and Dr. Hye Won Lee
Manuscript Submission Information
Manuscripts should be submitted online at https://ceog.imrpress.org by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a double-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on theInstructions for Authorspage. Clinical and Experimental Obstetrics & Gynecology is an international peer-reviewed open access quarterly journal published by IMR Press.
Please visit theInstructions for Authorspage before submitting a manuscript. The Article Processing Charge (APC)for publication in this open accessjournal is $1250. We normally offer a discount about 30% (APC: $850) to all contributors invited by the Editor-in-Chief, Guest Editor (GE) and Editorial board member. Submitted papers should be well formatted and use good English.
Women’s Health; Breast Cancer; Gynecology; Traditional Medicine; Complementary and Alternative Medicine; Integrative Medicine; Chinese Medicine